PRESS RELEASE published on 11/12/2024 at 08:30, 1 year 10 months ago Predilife lance une émission d'obligations de 2M EUR à un taux de 8,5% par an sur 5 ans
BRIEF published on 11/07/2024 at 18:35, 1 year 10 months ago Filialisation de MammoRisk par Predilife pour 202 M€ Développement International Valorisation MammoRisk Cancer Du Sein Filialisation
BRIEF published on 11/07/2024 at 18:35, 1 year 10 months ago Subsidiary of MammoRisk by Predilife for €202 million MammoRisk Breast Cancer International Development Subsidiary Valorization
PRESS RELEASE published on 11/07/2024 at 18:30, 1 year 10 months ago Réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 M EUR Predilife annonce la réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 M€ pour favoriser son développement international. Création de valeur et partenariats en vue Développement International Valorisation PREDILIFE MammoRisk Apport Partiel D'actif
BRIEF published on 10/30/2024 at 19:05, 1 year 10 months ago Predilife publie son rapport financier semestriel 2024 Euronext Growth Rapport Financier Intelligence Artificielle PREDILIFE Prédiction Médicale
BRIEF published on 10/30/2024 at 19:05, 1 year 10 months ago Predilife publishes its 2024 half-yearly financial report Artificial Intelligence Financial Report Euronext Growth PREDILIFE Medical Prediction
PRESS RELEASE published on 10/30/2024 at 19:00, 1 year 10 months ago Predilife met à disposition son rapport financier semestriel 2024 Predilife met à disposition son rapport financier semestriel 2024, spécialiste des solutions de prédiction de pathologies pour une médecine personnalisée Rapport Financier Médecine Personnalisée PREDILIFE Pathologies Prédiction
BRIEF published on 10/28/2024 at 08:35, 1 year 11 months ago Résultats Semestriels et Perspectives de PREDILIFE pour 2024 Résultats Financiers Partenariats Stratégiques Croissance 2024 PREDILIFE MammoRisk®
BRIEF published on 10/28/2024 at 08:35, 1 year 11 months ago PREDILIFE Half-Yearly Results and Outlook for 2024 Financial Results Strategic Partnerships Growth 2024 PREDILIFE MammoRisk®
PRESS RELEASE published on 10/28/2024 at 08:30, 1 year 11 months ago Résultats semestriels 2024 - Perspectives de croissance 2024 Annonce des résultats semestriels 2024 et perspectives de croissance pour PREDILIFE, spécialiste des solutions de prédiction de risques de pathologies. Des partenariats stratégiques et une croissance attendue Croissance Résultats Semestriels Partenariats Stratégiques PREDILIFE Bilans Prédictifs
Published on 09/29/2026 at 15:00, 1 hour 46 minutes ago As Crisis Events Intensify, BlackBerry and the American Red Cross Renew Commitment to Secure and Trusted Emergency Communications
Published on 09/29/2026 at 14:45, 2 hours 1 minute ago NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials
Published on 09/29/2026 at 14:30, 2 hours 16 minutes ago Solitario Resources Presentation Change of Time at the 38th Annual Mining Forum Americas 2026 Conference
Published on 09/29/2026 at 14:30, 2 hours 16 minutes ago Hillcrest ZVS Technology Demonstrates More Than 90% Reduction in Motor Voltage Spikes
Published on 09/29/2026 at 16:23, 23 minutes ago Sonova named Switzerland’s most innovative large company
Published on 09/29/2026 at 16:15, 30 minutes ago Behind the success of Ecuador's bananas: Sustainability investments that retail prices fail to reflect says AEBE
Published on 09/29/2026 at 16:00, 46 minutes ago Leadership Transition at DEAG: Markus Breitenecker to Succeed Detlef Kornett as Chairman of the Executive Board
Published on 09/29/2026 at 15:58, 47 minutes ago mobilezone awarded EcoVadis Silver Medal for sustainability performance
Published on 09/29/2026 at 14:15, 2 hours 30 minutes ago 260929 BENETEAU Mise en oeuvre du programme de rachat d'actions
Published on 09/29/2026 at 12:15, 4 hours 30 minutes ago NRJ GROUP - Affaire Fun Radio - Report du délibéré de la Cour d'appel
Published on 09/29/2026 at 08:45, 8 hours 1 minute ago Cegedim Santé réinvente l’accès à l’information médicale en déployant l’Assistant by Claude Bernard IA sur toutes ses solutions de médecine de ville
Published on 09/28/2026 at 17:54, 22 hours 51 minutes ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 22 hours 51 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
